Product News and Recalls

FDA Details Connection Between Breast Implants and Rare Cancer Type

warnings issued over textured breast implants and cancerThe FDA issued its first warning about a possible link between textured breast implants and an exceedingly rare type of breast cancer known as anaplastic large cell lymphoma, or ALCL, in 2011. Now, some six years later, dangerously little remains known about the disease.

At this time, the exact number of cases of ALCL is extremely difficult to determine because of a lack of data on implant ...

continue reading...

Gout Medication Subject of FDA Safety Communication

febuxostat prompts fda communicationPatients taking febuxostat (marketed as Uloric) to treat gout will want to pay particular attention to a recent warning issued by the FDA. Last month, the agency released a preliminary alert over concerns that the medication might be responsible for an increased risk of cardiac-related events that could lead to death when compared to an existing medication that could be used as an alternative.

Takeda Pharmaceuticals makes the drug and has been under FDA ...

continue reading...

Medical Expert Offers Tips for Women to Avoid Talc

tips for avoiding talcThousands of cases are pending against Johnson & Johnson across the country, as plaintiffs claim the world’s largest home health goods company’s talc products cause ovarian cancer. Juries have awarded hundreds of millions of dollars in cases that have already been decided, though recent appeals won by J&J have made their own waves through courts.

Still, scientific studies do appear to have found a definitive link between talc and ovarian cancer. One even ...

continue reading...

First Testim Trial Ends with Decision in Favor of Drugmaker

testim trial sides with drugmakerTestim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.

The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since then has ...

continue reading...

FDA Issues Safety Announcement for New Liver Disease Drug

fda issues statement on OcalivaBloomberg reports that the FDA has issued a safety announcement for Intercept’s Ocaliva, a drug designed for a rare liver disease known as primary biliary cholangitis. The announcement comes after at least 19 deaths were attributed to the medication, which was only introduced in May of 2016.

Intercept claims to have explicitly warned doctors of the specificity with which they must prescribe Ocaliva and how it must be taken by patients. ...

continue reading...

Johnson & Johnson Loses Another Hip Implant Jury Trial

DePuy Orthopedics loses another big jury trialThe total amount awarded to patients implanted with metal-on-metal hip implants from Johnson & Johnson’s DePuy Orthopedic unit grew by over a quarter of a billion dollars this month in the latest Dallas jury verdict. This represents the corporation’s third significant loss in a matter that has close to 10,000 additional plaintiffs waiting for their own days in court.

For those that have been following these cases, this ...

continue reading...
Page 1 of 309 12345...»